Cargando…

Evaluation of prescriptions of medicines not included in Iran medicine list: A cross-sectional study

OBJECTIVE: Iran Food and Drug Administration (IFDA) has the mission to regulate all aspects of pharmaceutical market including registration of the new medicines. Iran Drug Selection Committee has the responsibility to maintain and revise Iran Medicine List (IML). The National law has banned producti...

Descripción completa

Detalles Bibliográficos
Autores principales:	Zargaran, Marzieh, Nikfar, Shekoufeh, Cheraghali, Abdol Majid
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Medknow Publications & Media Pvt Ltd 2016
Materias:	Original Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5084479/ https://www.ncbi.nlm.nih.gov/pubmed/27843958 http://dx.doi.org/10.4103/2279-042X.192456

Ejemplares similares

Trends in Iran Pharmaceutical Market
por: Cheraghali, Abdol Majid
Publicado: (2017)

A system dynamics model for national drug policy
por: Abdollahiasl, Akbar, et al.
Publicado: (2014)

Cost effectiveness of Iran national plasma contract fractionation program
por: Cheraghali, Abdol Majid
Publicado: (2012)

Biosimilars; a unique opportunity for Iran national health sector and national pharmaceutical industry
por: Cheraghali, Abdol Majid
Publicado: (2012)

Policies and measures implemented to reduce the impact of international sanctions on Iran's pharmaceutical sector
por: Emami, Farideh, et al.
Publicado: (2022)

Heavy Metals Contamination of Table Salt Consumed in Iran
por: Cheraghali, Abdol Majid, et al.
Publicado: (2010)

Evaluation of COVID-19 Treatments in Iran in Comparison with Local Therapeutic Recommendations: A Population-Level Study on Utilization and Costs of Prescription Drugs
por: Hashemi-Meshkini, Amir, et al.
Publicado: (2022)

Assessment of Frequency and Causes of Medication Errors in Pediatrics and Emergency Wards of Teaching Hospitals Affiliated to Tehran University of Medical Sciences (24 Hospitals)
por: Izadpanah, Fatemeh, et al.
Publicado: (2018)

Challenges of access to medicine and the responsibility of pharmaceutical companies: a legal perspective
por: Ahmadiani, Saeed, et al.
Publicado: (2016)

Withdrawn medicines included in the essential medicines lists of 136 countries
por: Charles, Onella, et al.
Publicado: (2019)

The case for levetiracetam to be included in essential medicine lists
por: Singh, Gagandeep, et al.
Publicado: (2023)

Achieving Equitable Access to Medicines and Health Services: A COVID-19-time Recalled Matter
por: Mousavi, Taraneh, et al.
Publicado: (2021)

Evaluation of medicine prescription pattern using World Health Organization prescribing indicators in Iran: A cross-sectional study
por: Karimi, Aliasghar, et al.
Publicado: (2014)

Implications of Confidential Unit Exclusion in Providing Sufficient Safe Blood for the National Health System
por: Cheraghali, Abdol Majid
Publicado: (2011)

Blood safety concerns in the Eastern Mediterranean region
por: Cheraghali, Abdol Majid
Publicado: (2011)

Impacts of international sanctions on Iranian pharmaceutical market
por: Cheraghali, Abdol Majid
Publicado: (2013)

Direct and indirect cost of managing Alzheimer’s disease in the Islamic Republic of Iran
por: Aajami, Zahra, et al.
Publicado: (2019)

Precision Medicine in Non Communicable Diseases
por: Hasanzad, Mandana, et al.
Publicado: (2019)

Efficacy and tolerability of renzapride in irritable bowel syndrome: a meta-analysis of randomized, controlled clinical trials including 2528 patients
por: Mozaffari, Shilan, et al.
Publicado: (2014)

Pharmacists Remuneration Models in Iran and Selected Countries: a Comparative Study
por: Hashemi-Meshkini, Amir, et al.
Publicado: (2013)

Bioactive Foods and Medicinal Plants for Cardiovascular Complications of Type II Diabetes: Current Clinical Evidence and Future Perspectives
por: Bahramsoltani, Roodabeh, et al.
Publicado: (2021)

Evaluation of medicine prescription pattern
por: Tin, Sim Sai, et al.
Publicado: (2014)

Monitoring of National Drug Policy (NDP) and its standardized indicators; conformity to decisions of the national drug selecting committee in Iran
por: Nikfar, Shekoufeh, et al.
Publicado: (2005)

Explanation of Socio-economic Inequality in Medicine Use: A Cross-sectional Analysis from Iran
por: Torabipour, Amin, et al.
Publicado: (2022)

A Systematic Review of Discrete Choice Experiment Studies in Rheumatoid Arthritis Biological Medicines
por: Zartab, Saman, et al.
Publicado: (2021)

Pattern of Antidepressant Utilization and Cost in Iran from 2006 to 2013 in Comparison with Other Countries
por: Soleymani, Fatemeh, et al.
Publicado: (2018)

Cost analysis of childhood asthma in Iran: A cost evaluation based on referral center data for asthma and allergies
por: Rezvanfar, Mohammad Ali, et al.
Publicado: (2013)

Trend analysis of the pharmaceutical market in Iran; 1997–2010; policy implications for developing countries
por: Kebriaeezadeh, Abbas, et al.
Publicado: (2013)

Prescription of medicines by medical students of Karachi, Pakistan: A cross-sectional study
por: Zafar, Syed Nabeel, et al.
Publicado: (2008)

Assessment of the vaccine industry in Iran in context of accession to WTO: a survey study
por: Hashemi Meshkini, Amir, et al.
Publicado: (2012)

Financial perspective of private pharmacies in Tehran (Iran); is it a lucrative business?
por: Keshavarz, Khosro, et al.
Publicado: (2012)

Cost-effectiveness and budget impact analysis of lisdexamfetamine versus methylphenidate for patients under 18 with attention-deficit/hyperactivity disorder in Iran
por: Tajik, Amirmohammad, et al.
Publicado: (2023)

Evidence for the effectiveness of anti-hypertensive medicines included on the Chinese National Reimbursement Drug List
por: Liu, Wenbin, et al.
Publicado: (2019)

Cladribine tablets are a cost-effective strategy in high-disease activity relapsing multiple sclerosis patients in Iran
por: Ayati, Nayyereh, et al.
Publicado: (2021)

Commercialization of biopharmaceutical knowledge in Iran; challenges and solutions
por: Nassiri-Koopaei, Nasser, et al.
Publicado: (2014)

Storage of prescription veterinary medicines on UK dairy farms: a cross-sectional study
por: Rees, Gwen M, et al.
Publicado: (2019)

A Cost-Utility Analysis of Different Antiviral Medicine Regimens in Patients With Chronic Hepatitis C Virus Genotype 1 Infection
por: Alavian, Seyed Moayed, et al.
Publicado: (2016)

Monographs for medicines on WHO’s Model List of Essential Medicines
por: Roth, Lukas, et al.
Publicado: (2018)

Challenges in updating national guidelines and essential medicines lists in Sub‐Saharan African countries to include WHO‐recommended postpartum hemorrhage medicines
por: Ng'ang'a, Joyce, et al.
Publicado: (2022)

Budget impact analysis of vaccination against Haemophilus influenzae type b as a part of a Pentavalent vaccine in the childhood immunization schedule of Iran
por: Teimouri, Fatemeh, et al.
Publicado: (2017)

Cannot write session to /tmp/vufind_sessions/sess_ke144qrl0928uputvb4vmfihag